Swiss based natural product specialist – Similasan – has obtained CE Mark certification for four new eye care products: Similasan Itchy Eye®, Dry Eye®, Pink Eye® and Strained Eye® Drops.
Similasan.gifCurrently the No2 eye care brand in Switzerland and Austria, the CE mark will enable Similasan access to other European markets.
With approved regulatory status as medical devices, this mark indicates that the products meet strict criteria enabling them to be freely distributed and marketed across the EU.
Similasan have now announced plans for an intensive market entry programme for its new eye drop range into Europe and has been working with GBT Pharma, a consultancy specializing in international business development for healthcare brands, to widen their distribution.
Urs Lehmann CEO of Similasan comments: “GBT Pharma’s new market entry programme for our eye drop brands most recently saw the launch into Latin America confirmed. Our market entry programme into Europe is also now well underway.
“GBT Pharma have guided us through the necessary regulatory pathways to achieve this growth and this latest CE mark approval means our popular eye drop products can be freely marketed anywhere in the EU.
“We are actively encouraging companies interested in distribution opportunities to contact the GBT Pharma team at this very exciting stage of the project.”